Pharmaceutical Industry

Manufacturing Pharmaceuticals Trade Policy Stock Market Investment Drug Manufacturing Sales Performance Corporate Strategy Corporate Finance Drug Development

3 ARTICLES

2w ago

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

The Holly Springs site will support next-generation obesity drugs, creating 400 permanent jobs and enhancing U.S. pharmaceutical manufacturing capacity.

3 ARTICLES

3w ago

Charles River Labs Reshapes Board and Launches Strategic Review Following Elliott Deal

6 ARTICLES

4w ago

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

10 ARTICLES

4w ago

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

3 ARTICLES

last mo.

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

5 ARTICLES

3mo ago

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

Pharmaceutical Industry

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

Charles River Labs Reshapes Board and Launches Strategic Review Following Elliott Deal

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Senators Question RFK Jr.'s Mar-a-Lago Dinners with Big Pharma Executives

Alliance Pharma Backs £362m Takeover by DBAY Advisors

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe